Press release
Psoriasis Drugs Market Size - Forecasts to 2026
Psoriasis Drugs Market
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Psoriasis Drugs Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/psoriasis-drugs-market-3419
By Treatment Type (Topicals, Systemic, Biologics), By Therapeutic Class (Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors, Anti-Inflammatory, Corticosteroids, Vitamin D Analogues), By Application (Plaque Psoriasis, Guttate Psoriasis, Nail Psoriasis, Erythrodermic Psoriasis, Pustular Psoriasis, Intertriginous Psoriasis, Others), By Distribution Channel (Hospitals & Clinics, E-commerce, Retail Pharmacies), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
• Owing to technological breakthroughs, personalized medicine is rapidly gaining momentum in the market as an important element of value-based medication that strives to improve the quality of treatment.
• Biologic-based medications are foreseen to predominate because it provides patients with superior symptom supervision and management, as well as an enhanced quality of living.
• The market for tumor necrosis factor inhibitors is estimated to predominate owing to the potential to mitigate inflammation.
• The market for nail psoriasis is estimated to predominate because of the condition's elevated incidence rate.
• Systemic medications and phototherapy aids in the supremacy of the hospitals & clinics segment.
• High therapeutic enactment and the involvement of key manufacturing companies aids in the predominance of the North American region.
• UCB, Novartis AG, Merck, Johnson & Johnson, Eli Lilly & Company, Celgene Corporation, Boehringer Ingelheim, AstraZeneca, Amgen Inc, AbbVie Inc., Pfizer Inc., Janssen Biotech Inc, Stiefel Laboratories Inc, and Takeda Pharmaceutical Company Limited, among others, are the key players in the market.
Browse the Report @ https://www.globalmarketestimates.com/market-report/psoriasis-drugs-market-3419
Treatment Type Outlook (Revenue, USD Billion, 2021-2026)
• Topicals
• Systemic
• Biologics
Therapeutic Class Outlook (Revenue, USD Billion, 2021-2026)
• Tumor Necrosis Factor Inhibitor
• Interleukin Inhibitors
• Anti-Inflammatory
• Corticosteroids
• Vitamin D Analogues
Application Outlook (Revenue, USD Billion, 2021-2026)
• Plaque Psoriasis
• Guttate Psoriasi
• Nail Psoriasis
• Erythrodermic Psoriasis
• Pustular Psoriasis
• Intertriginous psoriasis
• Others
Distribution Channel Outlook (Revenue, USD Billion, 2021-2026)
• Hospitals and Clinics
• E-commerce
• Retail Pharmacies
Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA
Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Drugs Market Size - Forecasts to 2026 here
News-ID: 2339201 • Views: …
More Releases from Global Market Estimates Research & Consultants
Global Market Estimates Hosts Exclusive Webinar on Future Trends in Quick Commer …
Gain Strategic Insights and a Comprehensive Report on August 1st
Global Market Estimates (GME) is excited to announce an exclusive webinar, "Future Trends in the Global Quick Commerce Market: Forecasts to 2029," scheduled for August 1, 2024, at 11am EST. This insightful session will feature Mr. Yash Jain, Director - Global Accounts & Strategic Advisory.
For a registration fee of USD 499, attendees will receive a comprehensive report valued at USD 5,450,…
Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029.
Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market Insights
• As per…
Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029.
Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market…
Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029.
Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded…
More Releases for Psoriasi
Chronic Plaque Psoriasis Market was valued at USD 24.5 billion in 2024 and is pr …
Chronic Plaque Psoriasis Market Overview
The Chronic Plaque Psoriasis Market was valued at USD 24.5 billion in 2024 and is projected to reach USD 43.8 billion by 2034, growing at a CAGR of around 6.2%. Growth is fueled by rising disease prevalence, strong uptake of biologics, and continuous expansion of dermatology specialty care.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71377
Key Market Drivers
• Increasing global prevalence of moderate to severe plaque psoriasis.
• Rapid…
Moderate to Severe Plaque Psoriasis Market is expected to reach USD 43-48 billio …
Market Overview
The Moderate to Severe Plaque Psoriasis market continues to grow robustly, supported by rapid adoption of biologics, targeted oral therapies, and personalized treatment pathways. Psoriasis is a chronic immune-mediated inflammatory disease, and moderate to severe cases typically require systemic therapy due to the extent of skin involvement and impact on quality of life.
The global market for moderate to severe plaque psoriasis was valued at USD 27-30 billion in 2024.…
Mild to Moderate Plaque Psoriasis Market is Projected to reach USD 14-16 billion …
Market Overview
The Mild to Moderate Plaque Psoriasis market is expanding steadily as patient awareness grows, diagnosis rates improve, and demand increases for effective topical and systemic therapies. Plaque psoriasis-an immune-mediated inflammatory skin disorder-affects millions globally, with mild to moderate cases making up a substantial share of the total psoriasis burden.
The global market for mild to moderate plaque psoriasis was valued at USD 9-10 billion in 2024. With rising adoption of…
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Market Strengthens as Biologics, …
Plaque psoriasis-one of the most common chronic inflammatory skin diseases-affects millions globally and requires long-term, individualized clinical management. As biologics, targeted small molecules, and digital dermatology tools advance rapidly, the plaque psoriasis clinical market is entering a new era of therapeutic innovation. This press release highlights key trends, diagnostic advancements, market drivers, and segment insights driving the evolution of psoriasis care worldwide.
Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/73631
Market…
Pulp and Paper Market Growing from USD 351.7 Billion in 2024 to USD 518.2 Billio …
Introduction: The Timeless Industry Reinventing Itself
For centuries, the pulp and paper industry has played a vital role in global communication, education, packaging, and hygiene. Despite the digital age's influence, this market continues to evolve-driven by sustainable packaging demand, e-commerce growth, and the transition toward recyclable materials. As environmental awareness grows and plastic bans expand globally, pulp and paper products are becoming central to the circular economy.
According to Exactitude Consultancy, the…
Gaucher Disease Clinical Market to Reach $3.9 Billion by 2034, Growing at a 6.5% …
Introduction
Gaucher Disease (GD) is a rare inherited lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase, resulting in the accumulation of harmful fatty substances in organs such as the spleen, liver, and bone marrow. Though historically considered a niche orphan indication, the disease has gained major attention in the biotechnology and pharmaceutical industries due to increasing diagnosis rates, precision medicine innovations, and strong clinical research activity in enzyme…
